BNP Paribas Financial Markets
PHAR

BNP Paribas Financial Markets’s Pharming Group PHAR Stock Holding History

BNP Paribas Financial Markets’s Portfolio PHAR Stock Details PHAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.17K Sell
300
-100
-25% -$1.45K ﹤0.01% 5478
2026
Q1 		$6.66K Sell
400
-400
-50% -$6.78K ﹤0.01% 5283
2025
Q4 		$14.1K Buy
800
+700
+700% +$11K ﹤0.01% 5096
2025
Q3 		$1.45K Buy
+100
New +$1.25K ﹤0.01% 5197

Other funds holding PHAR

MACM
MAC Alpha Capital Management Tampa, Florida $216M AUM
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM
KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
SGFG
Silver Grove Financial Group Orchard Park, New York $185M AUM 28.01% 1-Year Est. Return
NSG
Nalls Sherbakoff Group Knoxville, Tennessee $141M AUM 25.05% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM

BNP Paribas Financial Markets's PHAR Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Pharming Group (PHAR) stake by 25% in Q2 2026, selling an estimated $1.45K and leaving 300 shares worth $4.17K. The position accounts for ﹤0.01% of the portfolio, ranked #5478.

BNP Paribas Financial Markets first reported a position in PHAR in Q3 2025 and has held it in 4 quarters since. The position peaked at $14.1K in Q4 2025. 17 funds tracked by Wall St. Rank hold PHAR as of Q2 2026.

  • BNP Paribas Financial Markets held 300 shares of Pharming Group worth $4.17K as of Q2 2026.
  • BNP Paribas Financial Markets sold 100 Pharming Group shares in Q2 2026, an estimated $1.45K.
  • Pharming Group made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5478 holding.
  • BNP Paribas Financial Markets first reported a position in Pharming Group in Q3 2025 and has held it in 4 quarters since.
  • BNP Paribas Financial Markets's Pharming Group position peaked at $14.1K in Q4 2025.
  • 17 funds tracked by Wall St. Rank held Pharming Group as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.